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Understanding the Personal and Clinical Utility
of Psychiatric Advance Directives:
A Qualitative Perspective
Mimi M. Kim, Richard A. Van Dorn, Anna M. Scheyett, Eric E. Elbogen,
Jeffrey W. Swanson, Marvin S. Swartz, and Laura A. McDaniel
Psychiatric advance directives (PADs) are legal tools that allow competent individuals to declare preferences for future mental health treatment when they may
not be capable of doing so as a result of a psychiatric crisis. PADs allow individuals to maintain self–determination during times when they are most vulnerable to
loss of autonomy and in need of assistance to make their preferences known and
honored. This article describes the content of twenty–eight open–ended,
semi–structured qualitative interviews of adults with PADs who have experienced
psychiatric crises. The qualitative analysis revealed three major themes from the
interviews: (1) PADs as tools for empowerment and self–determination, (2) limited knowledge of PADs among service providers; and (3) difficulties communicating PADs to inpatient staff. In general, many participants expressed
enthusiasm of the implementation of PADs but concern regarding clinicians’ general lack of awareness about them. Additionally, some consumers discussed discomfort in even mentioning that they had a PAD to clinicians for fear of a negative
response from them, or some type of involuntary treatment during their hospitalization. However, participants consistently viewed PADs as a positive tool to promote autonomy with the potential to facilitate stronger patient–provider
relationships. Therefore, when working with individuals in psychiatric crisis who
have a PAD, and who have never before experienced a sense of control over their
own treatment, clinicians must recognize the potential troubling disequilibrium
this sense of control may engender. In sum, though the most significant challenges
facing the implementation of PADs involve clinicians’ familiarity with and
education about PADs, much promise for the future growth of PADs lies in the
benefits perceived by the patients.
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It felt like, I don’t know, I was just really
scared. Sometimes I have a hard time remembering things or telling people things what I
want and certain stuff and it felt like I was all
alone inside there.
–Adult study participant
describing a recent hospitalization

Individuals with severe mental illnesses
(SMI) often describe a sense of confusion,
fear, and inability to communicate their treatment wishes and have them respected during a
crisis. Psychiatric advance directives (PADs)
are one potential mechanism available to persons with SMI to help minimize many of the
ambiguities commonly associated with mental health crises. PADs are legal documents
that allow competent individuals, through advance instructions (AI) and/or designation of
a Health Care Agent (HCA), to declare preferences for future mental health treatment when
they may not be capable of doing so as a result
of a psychiatric crisis (Appelbaum, 2004;
Joshi, 2003; Swartz, Swanson, & Elbogen,
2004). This study uses qualitative interviews
with adults with SMI who had completed a
PAD and had a subsequent mental health crisis to examine consumer views on and
experiences with PADs and mental health
services.
BACKGROUND

A growing body of literature posits
manifold benefits of PADs for individuals
with SMI. Specifically, it has been proposed
that PADs have the potential to increase autonomy, decrease the need for coercive interventions, and improve clinical outcomes
through an increase in provision of preferred
services during crises, improved engagement
in the treatment process, and an enhanced
sense of self–efficacy, connection, and empowerment (Backlar & McFarland, 1998;
Howe, 2000; Srebnik & LaFond, 1999;
Swanson et al., 2000; Widdershoven &
Berghmans, 2001). However, the literature
also notes a number of potential barriers to
PAD implementation and effectiveness. These

include low rates of PAD creation by consumers (Swanson, J.W., Swartz, M.S., Ferron, J.,
Elbogen, E.B., Van Dorn, 2006), operational
features of the mental health service system
(e.g., lack of communication between staff,
lack of access to the document), or clinical
barriers (e.g., inappropriate treatment requests, such as refusal of necessary medications; consumers’ desire to change their mind
about treatment during crises) (Van Dorn et
al., 2006).
In addition, PADs shift authority from
the provider to a relationship based more on
shared decision–making. In the absence of
clinical alliance, some providers may be reticent to inform individuals with SMI about
PADs, work with them in creating PADs, or
invoke the PAD during crises. A number of
studies report varying levels of clinician support for PADs. These estimates range from a
low of 20% to over 80% of clinicians indicating their support for PADs (Amering et al.,
1999; Atkinson, Garner, & Gilmore, 2004;
Backlar et al., 2001; Elbogen et al., 2006;
Srebnik 2004). Given the novelty of PADs,
such varying rates of PADs endorsement, particularly the lower rates, are not surprising.
One study found that eight to ten months after
creating a PAD, 46% of persons with SMI expressed concern or dissatisfaction with it, primarily as a result of providers’ lack of education about PADs and lack of willingness to
honor them (Backlar et al., 2001). Elbogen
and colleagues (in press) examined the opinions of 591 clinicians (psychiatrists, psychologists, and social workers) to assess their attitudes and decision–making in relation to
PADs. They found that approximately 51%
of the clinicians were unsure of the impact of
PADs.
Given the fairly recent introduction of
PADs to both consumers and providers, multiple questions remain, including the consumers’ reasons for completing PADs, their views
on the utility of PADs, and the most efficient
process for communicating not only that one
has a PAD, but also its contents during times
of crisis. For example, what role, if any, does
direct, personal experience with involuntary
treatment play in consumers’ decisions to
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complete a PAD? Can consumers demonstrate
appropriate insight regarding the risks and
benefits of completing a PAD? This issue is especially important because the participants’
understanding of PADs will shape their expectations of what the PAD can offer them. Without a clear understanding, consumers may become disenchanted or disappointed by PADs,
threatening the long–term utility of PADs in
their treatment. Related questions arise when
considering PADs in the context of crisis
events. For example, are PADs reviewed and
honored by clinicians during crises? If so, how
does honoring the PAD impact the consumer?
C o n v e r s e l y , w h a t a r e t h e ef f e c t s o n
consumers’ overall treatment outcomes when
the PAD is not honored during a crisis?
This study seeks to address these questions through the examination of qualitative
interviews of persons with SMI who completed a PAD with the assistance of a facilitator and had a subsequent crisis during which
they were either hospitalized or felt they
should have been hospitalized. The paper explores and reports on these individuals’ experiences with the mental health system before,
during, and after the crisis, the impact of the
PAD on their crisis and mental health care,
and their general views regarding the usefulness of PADs. We then discuss the implications of the findings as they relate to consumers’ support of PADs; the pattern of provider
interactions with PADs, particularly during
crisis situations; and the overall utility of
PADs in mental health treatment.
METHOD

These data were collected as part of a
larger, longitudinal, randomized control trial
(RCT) that examines the effects of a facilitated Psychiatric Advance Directive (F–PAD)
intervention on three sets of outcomes: (1)
PAD completion, structure, and content; (2)
outpatient treatment engagement; and (3) crisis management. The primary target population for PADs is a subset of adults with SMI
who experience psychotic symptoms associated with fluctuating decisional capacity and
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who are at risk for involuntary treatment. Accordingly, the study’s sample criteria were as
follows: (1) age 18–65; (2) chart diagnosis of
schizophrenia, schizoaffective disorder, other
psychotic disorder, or major mood disorder
with psychotic features; and (3) currently receiving community–based treatment provided
through one of two county–based programs
in the state mental health system of North
Carolina, located in the north–central region
of the state); (4) able to give informed consent
to the study, which entails the ability to participate in a research interview in English and
provide informative answers to basic questions about personal background, previous
mental health treatment, and preferences for
and against given forms of treatment. At the
conclusion of the RCT baseline interview,
each participant received random assignment
to the F–PAD intervention or control group.
A sample of 469 patients with SMI were
randomly assigned to the F–PAD session or a
control group receiving written information
about PADs and a referral for assistance from
existing resources in the public mental health
system. Prior to giving informed consent, the
research staff member explained the benefits
of being in each group. Specifically, if assigned
to the F–PAD group, a research staff member
would help the participant complete a PAD. If
assigned to the control group, the research
staff would provide the participant with information on how to complete the PAD. Also,
control group participants would be given extra help completing a PAD once the study participation was completed. If the participant
wished to receive help before the study ended,
he/she was offered an opportunity to attend a
group meeting about PADs and the phone
number of a consumer organization that
could assist them with the completion of the
PAD. Sixty–one percent of F–PAD participants completed legal advance instructions
and/or authorized a proxy decisionmaker; 3
percent of control group participants
completed these legal instruments.
Since the questions explored in this
study concern consumers’ subjective experiences and views on PADs, a qualitative methodology was chosen. A qualitative approach
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explores individual experiences and “alternative ways of knowing” by using dialogue and
emergent themes that delve beneath the surface of aggregate data (Guba, 1990). Qualitative methodologies are particularly relevant
when the issues under investigation are relatively new and questions have yet to be clearly
and completely explicated (Amering, Stastny,
& Hopper, 2005), as is the case with the
current state of PADs.
An open–ended and exploratory set of
questions was developed by the authors to explore concepts related to consumer insight,
awareness of risks and benefits of PADs, treatment preferences, patient–provider interactions around treatment preferences, and perceived benefits of PADs. Throughout the data
collection process, data were continually examined for the purposes of modifying the
wording of future interview questions to
better focus on the emergent themes in greater
depth. This initial stage of analysis followed a
grounded theory approach. This approach
follows a traditionally qualitative recursive
and iterative process where the earlier interviews are referenced in order to inform and
shape future inquiries (Burck, 2005). This approach is appropriate for discovery–oriented
research and is most often used in under–theorized areas of research (Burck, 2005; Glaser &
Strauss, 1967; Henwood & Pidgeon, 1996).
Twenty–eight open–ended interviews
were conducted by three members of the research team who were experienced with qualitative research as well as the larger RCT. Participants were recruited from the larger RCT
after they reported a recent mental health crisis and agreed to take part in this qualitative
project. The definition of crisis included both
hospitalization and feeling the need to be hospitalized The inclusion of the latter group was
based on the belief that PADs may help certain
people avoid hospitalization. The sample of
participants included 16 females and 12
males. Of the 28 participants, 64 percent (n =
18) were African American and 36 percent (n
= 10) were Caucasian. The median age of the
28 participants was 42 years and the median
reported age of onset for mental health and
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substance abuse problems was 22 years of
age.
The qualitative research staff contacted
each participant by phone after they provided
initial consent to the RCT interviewer. During
this follow–up interaction on the phone, the
qualitative interviewer explained the purpose
of the interview and also confirmed that the
participant had a PAD at the time of the reported mental health crisis. The interviewer
also explained that the interview would last
between 1 and 2 hours. Participants were then
asked if they had any questions and whether
they were still willing to take part in the study
(only one individual refused to participate in
the qualitative arm of the study). Once the
participant agreed to complete a qualitative
interview, he/she met with the interviewer in
person to complete the taped, face–to–face interview. The interview began with another
brief explanation of the objectives of the
study, and then each participant provided
written informed consent to take part in the
tape–recorded interview. The interviewer explained that each interview would be transcribed without any identifying characteristics in order to preserve the anonymity of the
participants; each participant was compensated $30 for their participation. All
interviews were transcribed and then coded by
one member of the research team using
Atlas.ti, version 4.1.
RESULTS

Analysis revealed three major themes
from the interviews: 1) PADs as tools for empowerment and self–determination, 2) limited
knowledge of PADs among service providers;
and 3) difficulties communicating PADs to
inpatient staff.
PADs as Tools for Empowerment and
Self–Determination
Throughout the qualitative interviews,
multiple themes related to PAD benefits
emerged. An important and recurrent theme
was the use of PADs as a way to maintain con-
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trol during a time of vulnerability. This control could be maintained through the advance
instruction (AI) function of the PAD by identifying specific hospitals to go to if hospitalized
and providing the primary clinician with a
copy of the PAD to refer to during crisis
events. As one participant explained:
Having a PAD makes me feel a little more
secure because like I said, if anything ever
happened to me, then I know that I’m not
going to go to just any hospital and be
treated by anybody. The doctors will hopefully have a copy of it. That’s why I want a
copy to give my doctors at [name of hospital] so that in case something happens to me,
they know how to treat me if I come into the
hospital.

Another participant remarked on the
benefit of specifying treatment refusals and
requests:
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In such an instance, the participant
gains the security of someone acting on their
behalf during a crisis situation; however, the
potential risk is the consumer’s disappointment if the HCPA makes a request that is not
clinically feasible at the time of crisis.
Consumers also indicated that PADs
were a tool to command respect from providers during crises. One participant stated that a
specific stipulation of his PAD was that he “be
treated with respect and to have them listen to
me.” A participant whose PAD had been read
and attended to during a crisis reported the
following:
The doctor didn’t treat me like a nut case because some hospitals do. You know what the
doctor said to me? [He said] “You’ve got
rights and it’s great that you know you have
them.” That’s what he said. He said to me,
“Now you know your rights and we’ll try to
respect those completely.”

Interestingly, even though many of the
participants that were interviewed reported
frustrations with not having their PADs acknowledged or honored, many of them still
expressed positive sentiments similar to the
following (from a participant who reported
that his PAD was not acknowledged by the
For other participants, the benefit of a hospital staff):
PAD was in identifying a legally recognized
It’s probably one of the best things that’s
proxy decision–maker, a Health Care Agent
come into mental health in a long time be(HCA). One participant described the potencause it gives you rights, while you’re sound
tial benefits of her HCA with the following:
Yes, I want control even if I’m not in control.
You know? Control issues are always an issue for me when an emergency occurs and if I
need to be admitted to a hospital and give up
controls, then I still want people to know
what’s best for me.

Say I need meds and it could be meds that I
don’t want, according to my PAD. So the
person that I gave [healthcare power of attorney – HCPA] to could go to my doctor and
say, well, she really needs this Haldol. If she
does not get this Haldol then, you know,
boom! The HCPA gives my HCPA the power
to say “go ahead.” See, [when I’m like this],
anything I say will be ignored because by me
being sick, they think that I am not in my
right mind so giving her the power of attorney allows her to take the next step.

and while you know what’s best for you –
and you’re the only person that knows
what’s best for you deep down. You know
what keeps you on track better than anybody. I would still recommend that at least
people consider [the PAD] because it’s nothing but beneficial. You know it’s got nothing
but good because people can have you committed and you don’t have a say about anything and that at least this way you do have
some say in your treatment if it’s read and
people see it and it’s legal – that’s another important thing about it
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Limited Knowledge of PADs among
Service Providers
Many participants identified barriers to
PAD implementation associated with providers’ lack of knowledge of or overall inertia to
PADs. In many cases, participants indicated
that clinicians were unaware of what a PAD
was, were unwilling to believe that the consumer had a PAD, or did not recognize the
PAD as an instrument to facilitate treatment.
The following is one individual’s experience
when he attempted to communicate with
service providers regarding his PAD:
I showed the police the medical bracelet [part
of the experimental procedure for the RCT]
to tell them I had a PAD and they just saw my
name but they didn’t call anybody. Then I
showed the doctor at mental health and I told
him that I had a PAD and he didn’t do nothing
. . . nobody told anybody at the hospital or
nothing. I mean I told everybody that I had a
living will registry [also part of the experimental procedure for the RCT] and they didn’t say
nothing. I thought maybe the doctor at mental health would have known about it but he
didn’t do anything. Then I had it [the bracelet]
on my wrist the whole time I was at the hospital but then they told me that I had to take it
off to be admitted; nobody even looked at it,
but they were telling me I had to take it off.

Another participant describes a similar
situation: “I told [my doctor] I had a PAD and
showed it to him. He just looked at me and
nodded sort of—that was it. He didn’t ask me
anything, didn’t tell me he was going to call
them [the living will registry to obtain a copy
of the document] or anything . . . ” A participant aptly described his frustrations when the
hospital didn’t ask him about his PAD: “The
PAD is supposed to be there for me when I
need it and I just couldn’t believe that [the doctors] didn’t know anything about it . . . For the
kind of money they charge you, you ought to
have some kind of rights.” When asked how
his hospital stay might have been different had
the staff been aware of his PAD, he said, “I
think that they would have at least recognized

the fact that I had some rights to say what
medications I wanted to be on, what they were
doing to me...”
Perhaps the most ubiquitous theme
emerging from these data was the need for
hospital staff to become more familiar with
and accepting of PADs. This is evidenced by
the following exchange between a consumer
and interviewer:
Interviewer: “ . . . but do you think they’ll
help you at all in the future?”
Consumer: “Maybe when more people start
using them.”
Interviewer: “Talk a little bit about
that—how would that help?”
Consumer: “Well a lot of people don’t even
know what it is, like the staff at the hospital.”

One participant conveyed his attempt
to overcome some of the barriers and potential risks associated with not having one’s
PAD available by making sure that all of the
relevant stakeholders in his treatment were
aware of and had a copy of it:
And the reason I gave so many people a copy
of it was if there needs to be a time when it
needs to be used, I don’t want any confusion
from anybody about what needs to be done .
. . If one person isn’t available, then another
person should be and if that person’s not
available, then someone else should be. Everybody I’ve showed it to, including my therapist, thinks it’s a great idea.

In some cases participants reported that
even when the PAD was reviewed by providers no attempt was made to follow the specified requests. One participant reported the
following:
When I got up to [mental health center] I told
them I had one [a PAD] and they said—their
excuse was, “We can’t always honor this because there may not be beds at this particular
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hospital, or so on and so on.” It was just a
complete run around. They weren’t treating
me with any respect.

Certainly, the practicality of specific
treatment requests cannot always be followed. As a result, in the main RCT, if a consumer was in the F–PAD group, research staff
explained the limitations that might interfere
with the implementation of certain aspects of
the PADs, such as bed availability. Research
staff emphasized that PAD treatment requests
should be perceived as preferences, but not
necessarily requirements.
Difficulties Communicating PADs to
Inpatient Staff
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n’t really paying me no attention, it was like I
wasn’t really there, I was just there to be admitted and I didn’t have no say–so about
nothing that I showed anyone. I didn’t want
to end up with them putting me in seclusion
or something so I just went along with whatever they said. So I didn’t want to get in no
trouble.

Though such behavior from clinical
staff seems to be less frequent than non–responsiveness to PADs because of unfamiliarity, PADs are a particularly valuable tool for
consumers like this who have experienced demoralizing staff during crisis situations. Another participant made a similar statement
when asked if she would feel comfortable
notifying staff of her PAD:

A number of participants stated that
they often did not volunteer information
It probably depends on the situation, you
about their PAD when in crisis. When asked if
know. I think if I feel like I’m in a hostile situshe had told anyone about her PAD when
ation, I might not consider it. But if I’m in a
taken to the hospital, one participant replied,
situation where I feel like there is respect and
“No, I didn’t tell anyone until the mental
concern for my situation, then I would probhealth doctor came in. I didn’t think of telling
ably be much more certain about doing it.
anyone until I saw him.” Another participant
commented on how difficult it was to rememFor some participants, having a PAD
ber the PAD once in crisis by saying the was a way to avoid or reduce future involunfollowing:
tary treatment in the hospital. A participant
expressed this by saying, “It means that I will
I don’t know, it’s still kind of hard to picture
have some say–so . . . That I’ll have some input
using or even remembering that I have an adinto what goes on in my treatment, and in my
vance directive if I have to go to the hospital
medication. That’s something I’ve never had
because when I’m that bad, sometimes I can’t
before.”
even remember my own name, much less to
let the hospital know that I’ve got this, what
is it again, oh yeah, psychiatric advance
directive.

In the current study, 65 percent of the
sample reported having experienced physical
involuntary treatment (such as restraint and
seclusion, or handcuffing) in the hospital (n =
Other participants appeared to be so 17). One participant described a sense of powconcerned about the potential for involuntary erlessness during a recent hospitalization with
treatment that it affected the way they inter- the following:
acted with hospital staff, particularly regarding communicating about the PAD. When
It was like I was just a patient there—they
asked if he told hospital staff he had a PAD,
didn’t want to have anything to do with me
one participant reported the following:
besides me just being a patient there as far as
No, I didn’t say nothing to those people
cause they was like—they wasn’t really listening to nothing that I had to say, they were-

carrying on a conversation or seeing how I
was on a day–to–day basis. None of that really seemed important to them. They were
just concerned with doing their job and that
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was it. I was just a patient to them. I had to
do what I was told. Move when I was told to
move and go to bed when I was told to go to
bed. It was just like that—really like I was in
prison.

This corroborates past research showing that PADs may be especially important for
those consumers who have experienced some
level of involuntary inpatient treatment in the
past (Srebnik & Brodoff, 2003; Swanson et
al., 2000).
Summary
These data provide an informative
glimpse into the experiences of persons with
SMI who reported having a mental health crisis after completing a PAD. Some of the experiences were positive and beneficial while others were clearly disheartening and frustrating
to those involved. Still, as evidenced by the following narrative, when clinicians are aware of
and have access to the PAD, and when the
stated preferences are respected by clinicians,
the beneficial aspects of PADs are apparent:
I pretty much carry my PAD around everywhere. I told the police about my PAD because they were the first people I spoke to
when I got taken to the hospital last time.
Then, when the ambulance took me to [name
of hospital], it was really crowded in the ER
so I showed intake my PAD and told them
that I needed to go somewhere quiet with less
people so that I could calm down because I
can’t be around a lot of people at once. The
intake nurse sat with me in a quiet room until
I calmed down.

DISCUSSION

Qualitative analyses revealed that
many participants expressed enthusiasm
about having a PAD but concern regarding
clinicians’ general lack of awareness of about
them. Additionally, some consumers discussed discomfort in even mentioning that
they had a PAD for fear of a negative response

from their clinician, or some type of involuntary treatment during their hospitalization.
However, participants consistently viewed
PADs as a positive tool to promote autonomy
with the potential to facilitate stronger
patient–provider relationships.
A number of implications related to
both clinical practice and future research can
be drawn from these findings. First, some participants experienced reticence regarding their
PAD and its potential to contribute to future
involuntary treatment during a mental health
crisis. Specifically, a number of participants
expressed concern about informing hospital
staff of their PAD for fear of not being paid attention to, or even worse, incurring some type
of punishment (e.g., being put in seclusion or
restraints) for mentioning the PAD. Other
participants communicated the potential for
clinicians to intimidate them during a
psychiatric crisis, thus deterring them from
introducing their PAD.
At the same time, while some participants did express these fears, several participants reported feeling “fortunate” to have a
“say–so” in their treatment, indicating that
this was something that they had “never had
before.” Therefore, when working with individuals in psychiatric crises who have a PAD,
and who have never before experienced a
sense of control over their own treatment, clinicians must recognize the potential disequilibrium this sense of control may engender.
Coupled with a history of involuntary treatment, this disequilibrium is likely to exacerbate discomfort with or intimidation by
hospital staff.
As a result, it appears important for clinicians to provide a safe environment to initiate discussions with consumers regarding
PADs. This sense of needed safety and respect
for the PAD was clearly expressed by one participant when she was asked to reflect on what
would help people in crisis feel more comfortable discussing their PAD with a clinician:
People with mental problems need [PADs] but
it’s not good if the doctor or whoever you
show the PAD to in the hospital can just crum-
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ble it up and throw it aside. It has to be read
and they have to have some respect for it.

While this sample appeared to have
good insight into their illnesses and treatment
needs, there were still instances where the concept of the PAD presented problems for some
consumers. Specifically, some participants reported problems remembering that they had a
PAD during a psychiatric crisis. However, the
majority of those interviewed indicated that
the PAD offered a sense of security during the
crisis. Specifically, they perceived the PAD as
an opportunity to inform staff of their own
psychiatric history, typical behaviors during
crises, and treatment preferences.
The main implication of this appears to
be that mental health service systems, particularly hospitals, ought to create an operational
structure that trains and allows staff to not
only inquire about PADs, but also to implement patients’ treatment requests (Van Dorn
et al., 2006). Findings from these data, in addition to prior research (Backlar et al., 2001;
Srebnik & Brodoff, 2003; Srebnik et al.,
2005) indicate that clinicians’ concerns that
PADs will be used to refuse all treatment have
largely been unfounded. Instead, it appears
that PADs are likely to be feasible, useful, and
in agreement with community standards of
care.
These qualitative data present perspectives of consumers able to identify both benefits and barriers associated with PADs. Specifically, participants identified the benefit of
having an HCA to enforce treatment choices
identified in the PAD, particularly proscriptive PADs where the consumer will stipulate
an imposed restraint or restriction in their
treatment. This was relevant for consumers
who either indicated adverse reactions to certain medications used in the past and thus proscriptively declined their future use, or those
who had responded well to certain treatments
and thus prescriptively requested their
continued use.
Furthermore, some participants discussed the sense of security that the PAD provided. For example, through the PAD, they
have a chance to express preferences for cer-
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tain hospitals where providers are aware of
their needs. However, some of the challenges
that participants associated with PADs included: not informing the provider of the PAD
(for multiple reasons as discussed above); clinicians not knowing what a PAD is; and clinicians not adhering to certain treatment preferences included in the PAD. One participant
described her doctor as feeling “overwhelmed” by her PAD, both because he was
unfamiliar with the concept of PADs and because of the copious amount of information in
her PAD. These potential risks and benefits of
PADs should be explored and examined in
greater detail to determine what length and
content is most effective for consumer and
clinician use.
These interviews also demonstrate that
providers’ exposure to PADs varies significantly. For instance, some participants described situations in which clinicians ignored
their claims of having a PAD. Others described scenarios where clinicians acknowledged the consumer having a PAD but did not
react to any treatment requests or comment
on the nature of the preferences. It has also
been found that clinicians may also consider
legal liability as a significant concern when
dealing with PADs and specified treatment
preferences (Van Dorn et al., 2006). But in
fact, because it is a fairly rare event for a consumer to be hospitalized and bring up having
a PAD, measuring how often clinicians are unaware of or ignore treatment requests
specified in a PAD becomes quite a challenge.
The same current state laws that authorize PADs also give providers discretion to ignore them (Swanson et al., 2006–a; Swanson
et al., 2006–b). Specifically, in cases where the
consumer’s advance choice of treatment conflicts with the provider’s view of the standard
of care, PAD laws do not require that the provider follow the patient’s wishes. In fact, most
of these laws provide broad legal immunity to
providers who, in good faith and consistent
with clinical standards, decline to follow a
consumer’s PAD (Swanson et al., in press–a;
Swanson et al., in press–b). Overall, clinicians
are obligated to follow whatever portions of
the PAD they can, even if they override some
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particular instructions. However, granting clinicians the discretion to decide which PAD instructions are to be followed, and which are
not, weakens the instrument to some degree.
Wea k ening P ADs ev en f urther, civ il
commitment law trumps a PAD in every U.S.
jurisdiction.
Despite these challenges, many participants reported both the current and future
value of PADs, not only when clinicians become more aware of the laws and documents,
but also more familiar with how to effectively
implement them. Perhaps most importantly,
the sample conveyed positive sentiments regarding the sense of security and rights PADs
afford people with mental illness. In some
cases, participants were able to describe the
positive impact PADs had on their treatment
when clinicians followed their PAD.
Given the small sample size and
grounded theory approach inherent in this
qualitative study, limitations regarding the
generalizability of these findings should be
considered. Many themes emerged, some
more positive than others. Some of the obvious and consistent themes include the extent
to which clinicians were unaware of PADs and
the potential benefit PADs present individuals
with severe mental illness, particularly those
with extensive mental health services and psy-

chiatric crisis experiences. As with any qualitative study built on the foundations of
grounded theory, these interviews and emergent themes provide a stepping stone from
which further study can build.
In sum, though the most significant
challenges facing the implementation of PADs
involve clinicians’ familiarity and education
about PADs, much promise for the growth of
PADs lies in the benefits perceived by consumers. The complexity of assimilating PADs into
mental health treatment involves not only
consumers, clinicians, and other key stakeholders, but also requires significant changes
in the infrastructure of the mental health service systems to integrate a legal tool that
strives to strengthen the consumer–provider
alliance in treatment delivery. This task is not
to be underestimated, especially when clinicians and the larger service system may face
the potential for inappropriate treatment
preferences and legal liability. But as PADs
gain wider acceptance among individuals
with SMI, clinicians, policy makers, and the
overall mental health system, future research
findings should replicate the benefits that
have been found in this study and increase the
promise of the application of PADs as a
frequently used treatment tool.
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